Literature DB >> 19049706

Patients undergoing dialysis therapy for 30 years or more survive with serious osteoarticular disorders.

S Yamamoto1, J J Kazama, H Maruyama, S Nishi, I Narita, F Gejyo.   

Abstract

AIMS: Increasing numbers of patients are undergoing long-term dialysis therapy. It is crucial for their quality of life to overcome dialysis-related complications, such as dialysis-related amyloidosis (DRA) and other osteoarticular disorder. The aim of the study was to investigate the characteristics, such as dialysis-related complications, in chronic kidney disease (CKD) Stage 5D patients undergoing dialysis therapy for more than 30 years or more.
METHODS: From 2003 to 2006, 359 CKD Stage 5D patients who were admitted to a single tertiary-care center. The age and the duration of dialysis therapy, the purpose for hospital admission, and history of osteoarticular disorder, such as carpal tunnel syndrome (CTS), destructive spondyloarthropathy (DSA) and joint arthropathy, were studied.
RESULTS: The proportions of the patients undergoing dialysis therapy for 20 - 24, 25 - 29 years and 30 years or more were 8.9, 5.6, and 4.5% of all admitted patients, respectively. DSA was a major cause of hospital admissions in long-term dialysis patients, especially in those treated for 30 years or more. The rate of surgery for osteoarticular disorder, such as CTS, DSA and joint arthropathy, which may show the presence of DRA, was 25.0, 66.0 and 77.8% in 20 - 24 years, 25 - 29 years and 30 years or more after the initiation of dialysis therapy, respectively. The frequency and severity of osteoarticular disorder accelerated with the duration of dialysis therapy, especially in those treated for 30 years or more. The rate of parathyroidectomy for secondary hyperparathyroidism was performed for 37.5% in 22.1 +/- 2.1 years after the initiation of dialysis treatment in the patients treated for 30 years or more. Mean age at the initiation of dialysis therapy was 27.3 +/- 8.0 years, and primary cause of CKD was mainly chronic glomerulonephritis in the patients undergoing dialysis therapy for 30 years or more.
CONCLUSION: CKD stage 5D patients undergoing dialysis therapy for 30 years or more survive with characteristics of younger age at initiation of dialysis therapy, chronic glomerulonephritis as a primary cause of CKD, and serious complication of osteoarticular disorders.

Entities:  

Mesh:

Year:  2008        PMID: 19049706     DOI: 10.5414/cnp70496

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  7 in total

1.  Increased risk of hip fracture among Japanese hemodialysis patients.

Authors:  Minako Wakasugi; Junichiro James Kazama; Masatomo Taniguchi; Atsushi Wada; Kunitoshi Iseki; Yoshiharu Tsubakihara; Ichiei Narita
Journal:  J Bone Miner Metab       Date:  2013-01-06       Impact factor: 2.626

2.  Rheumatic complications of long term treatment with hemodialysis.

Authors:  Nessrine Akasbi; Tarik Sqalli Houssaini; Latifa Tahiri; Hicham Hachimi; Chakib El Maaroufi; Randa El Youbi; Mohammed Arrayhani; Taoufik Harzy
Journal:  Rheumatol Int       Date:  2011-01-21       Impact factor: 2.631

3.  Effect of tetracyclines on the dynamics of formation and destructuration of beta2-microglobulin amyloid fibrils.

Authors:  Sofia Giorgetti; Sara Raimondi; Katiuscia Pagano; Annalisa Relini; Monica Bucciantini; Alessandra Corazza; Federico Fogolari; Luca Codutti; Mario Salmona; Palma Mangione; Lino Colombo; Ada De Luigi; Riccardo Porcari; Alessandra Gliozzi; Massimo Stefani; Gennaro Esposito; Vittorio Bellotti; Monica Stoppini
Journal:  J Biol Chem       Date:  2010-11-10       Impact factor: 5.157

4.  Using Covalent Labeling and Mass Spectrometry To Study Protein Binding Sites of Amyloid Inhibiting Molecules.

Authors:  Tianying Liu; Tyler M Marcinko; Patrick A Kiefer; Richard W Vachet
Journal:  Anal Chem       Date:  2017-10-26       Impact factor: 6.986

5.  Carpal tunnel syndrome in hemodialysis patients as a dialysis-related amyloidosis manifestation--incidence, risk factors and results of surgical treatment.

Authors:  Jerzy Kopeć; Artur Gadek; Maciej Drozdz; Krzysztof Miśkowiec; Julian Dutka; Antoni Sydor; Eve Chowaniec; Władysław Sułowicz
Journal:  Med Sci Monit       Date:  2011-09

6.  Positron Emission Tomography Can Support the Diagnosis of Dialysis-Related Amyloidosis.

Authors:  Giulia Santagati; Emanuela Cataldo; Valeria Columbano; Antoine Chatrenet; Daniele Penna; Ettore Pelosi; Mammar Hachemi; Lurlinys Gendrot; Louise Nielsen; Francesco Cinquantini; Patrick Saulnier; Vincenzo Arena; Charles Boursot; Giorgina Barbara Piccoli
Journal:  J Clin Med       Date:  2019-09-19       Impact factor: 4.241

Review 7.  Intradialytic Nutrition and Hemodialysis Prescriptions: A Personalized Stepwise Approach.

Authors:  Giorgina Barbara Piccoli; Francoise Lippi; Antioco Fois; Lurlynis Gendrot; Louise Nielsen; Jerome Vigreux; Antoine Chatrenet; Claudia D'Alessandro; Gianfranca Cabiddu; Adamasco Cupisti
Journal:  Nutrients       Date:  2020-03-16       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.